BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 17767740)

  • 1. How does endothelial cell injury start? The role of endothelin in systemic sclerosis.
    Abraham D; Distler O
    Arthritis Res Ther; 2007; 9 Suppl 2(Suppl 2):S2. PubMed ID: 17767740
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms of vascular damage in SSc--implications for vascular treatment strategies.
    Guiducci S; Distler O; Distler JH; Matucci-Cerinic M
    Rheumatology (Oxford); 2008 Oct; 47 Suppl 5():v18-20. PubMed ID: 18784130
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Statins and the vasculopathy of systemic sclerosis: potential therapeutic agents?
    Derk CT; Jimenez SA
    Autoimmun Rev; 2006 Jan; 5(1):25-32. PubMed ID: 16338208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endothelin receptor selectivity: evidence from in vitro and pre-clinical models of scleroderma.
    Shiwen X; Leask A; Abraham DJ; Fonseca C
    Eur J Clin Invest; 2009 Jun; 39 Suppl 2():19-26. PubMed ID: 19335743
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overview of pathogenesis of systemic sclerosis.
    Abraham DJ; Krieg T; Distler J; Distler O
    Rheumatology (Oxford); 2009 Jun; 48 Suppl 3():iii3-7. PubMed ID: 19487220
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Collagen V and vascular injury promote lung architectural changes in systemic sclerosis.
    Parra ER; Aguiar AC; Teodoro WR; de Souza R; Yoshinari NH; Capelozzi VL
    Clin Respir J; 2009 Jul; 3(3):135-42. PubMed ID: 20298396
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Systemic sclerosis].
    Ihn H
    Nihon Rinsho; 2009 Mar; 67(3):519-22. PubMed ID: 19280926
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The immunobiology of systemic sclerosis.
    Gu YS; Kong J; Cheema GS; Keen CL; Wick G; Gershwin ME
    Semin Arthritis Rheum; 2008 Oct; 38(2):132-60. PubMed ID: 18221988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic targets in systemic sclerosis.
    Denton CP
    Arthritis Res Ther; 2007; 9 Suppl 2(Suppl 2):S6. PubMed ID: 17767744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential benefit of statins for vascular disease in systemic sclerosis.
    Kuwana M
    Curr Opin Rheumatol; 2006 Nov; 18(6):594-600. PubMed ID: 17053504
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endothelin receptor antagonism--new perspectives in the treatment of systemic sclerosis.
    Kowal-Bielecka O; Sierakowski S
    Rocz Akad Med Bialymst; 2005; 50 Suppl 1():291-3. PubMed ID: 16119689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systemic sclerosis and infections.
    Randone SB; Guiducci S; Cerinic MM
    Autoimmun Rev; 2008 Oct; 8(1):36-40. PubMed ID: 18706530
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypoxia-induced increase in the production of extracellular matrix proteins in systemic sclerosis.
    Distler JH; Jüngel A; Pileckyte M; Zwerina J; Michel BA; Gay RE; Kowal-Bielecka O; Matucci-Cerinic M; Schett G; Marti HH; Gay S; Distler O
    Arthritis Rheum; 2007 Dec; 56(12):4203-15. PubMed ID: 18050252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vasoactive therapies in systemic sclerosis.
    Riemekasten G; Sunderkötter C
    Rheumatology (Oxford); 2006 Oct; 45 Suppl 3():iii49-51. PubMed ID: 16987836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Characteristic of the endogenous peptides--endothelins and their role in the connective tissue fibrosis].
    Garncarczyk A; Jurzak M; Gojniczek K
    Wiad Lek; 2008; 61(4-6):126-34. PubMed ID: 18939363
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endothelial dysfunction in systemic sclerosis.
    Altorok N; Wang Y; Kahaleh B
    Curr Opin Rheumatol; 2014 Nov; 26(6):615-20. PubMed ID: 25191994
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Future targets in the management of systemic sclerosis.
    Tyndall A; Matucci-Cerinic M; Müller-Ladner U
    Rheumatology (Oxford); 2009 Jun; 48 Suppl 3():iii49-53. PubMed ID: 19487225
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The pathology of scleroderma vascular disease.
    Fleming JN; Schwartz SM
    Rheum Dis Clin North Am; 2008 Feb; 34(1):41-55; vi. PubMed ID: 18329531
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Systemic sclerosis--introductory lecture].
    Kaliterna DM; Radić M
    Reumatizam; 2010; 57(2):90-3. PubMed ID: 21875010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of endothelial cells in the vasculopathy of systemic sclerosis: A systematic review.
    Mostmans Y; Cutolo M; Giddelo C; Decuman S; Melsens K; Declercq H; Vandecasteele E; De Keyser F; Distler O; Gutermuth J; Smith V
    Autoimmun Rev; 2017 Aug; 16(8):774-786. PubMed ID: 28572048
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.